Cargando…
Correction: RIPK3 expression in cervical cancer cells is required for PolyIC-induced necroptosis, IL-1α release, and efficient paracrine dendritic cell activation
Autores principales: | Schmidt, Susanne V., Seibert, Stefanie, Walch-Rückheim, Barbara, Vicinus, Benjamin, Kamionka, Eva-Maria, Pahne-Zeppenfeld, Jennifer, Solomayer, Erich-Franz, Kim, Yoo-Jin, Bohle, Rainer M., Smola, Sigrun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6633898/ https://www.ncbi.nlm.nih.gov/pubmed/31327986 http://dx.doi.org/10.18632/oncotarget.27066 |
Ejemplares similares
-
RIPK3 expression in cervical cancer cells is required for PolyIC-induced necroptosis, IL-1α release, and efficient paracrine dendritic cell activation
por: Schmidt, Susanne V., et al.
Publicado: (2015) -
RIPK3—a predictive marker for personalized immunotherapy?
por: Smola, Sigrun
Publicado: (2015) -
Necroptosis: Fifty shades of RIPKs
por: Ichim, Gabriel, et al.
Publicado: (2014) -
Type I Interferon Drives Dendritic Cell Apoptosis via Multiple BH3-Only Proteins following Activation by PolyIC In Vivo
por: Fuertes Marraco, Silvia A., et al.
Publicado: (2011) -
Chemoradiotherapy‐induced increase in Th17 cell frequency in cervical cancer patients is associated with therapy resistance and early relapse
por: Theobald, Laura, et al.
Publicado: (2021)